NFE2L2 and cardiomyopathy: Ferroptosis drives cardiomyopathy induced by chemotherapy (doxorubicin) in the mouse, where upregulation of Hmox1 seems important (Fang et al, 2019); this ferroptotic cardiomyopathy was abolished in Nrf2-deficent mice.